Why the study?
Cardiovascular disease and cancer frequently intersect, with atherosclerosis development promoted by aggressive anticancer therapies and shared risk factors, necessitating consideration of treatment features when both diseases coexist.
This review highlights the complex interrelations between atherosclerosis and cancer, emphasizing the need for tailored therapeutic strategies when both conditions are present.
Clinicians should consider integrated care for comorbid atherosclerosis and cancer; this Level 5 review leaves open optimal strategies for prospective validation.
Cardiovascular Conditions (CVD) as well as cancer are the main death causes globally. Characteristically, there are numerous interrelations and intersections between these two groups of diseases. So, in particular, cardiovascular disease is one of the main comorbidities and death causes in cancer patients. The development of atherosclerosis is promoted by aggressive anticancer therapy regimens and various risk factors, including hypertension, lipid metabolism disorders, and others. In this review, we considered the features of the treatment of atherosclerosis and cancer in the case of their simultaneous presence.
No takes yet. Share an insight, caveat, or question.
Poznyak et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: